中东和非洲放射治疗市场 – 行业趋势和 2029 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

中东和非洲放射治疗市场 – 行业趋势和 2029 年预测

  • Medical Devices
  • Published Report
  • Dec 2021
  • MEA
  • 350 页面
  • 桌子數: 138
  • 图号: 48

Middle East And Africa Mea Radiotherapy Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2023 –2029
Diagram Market Size (Base Year)
USD 157.48 Million
Diagram Market Size (Forecast Year)
USD 220.32 Million
Diagram CAGR
%
Diagram Major Markets Players
  • Elekta AB
  • RaySearch Laboratories
  • Brainlab
  • Koninklijke Philips N.V.
  • General Electric Company

>中东和非洲放射治疗市场,按类型(外束放射治疗、内束放射治疗、全身放射治疗/放射性药物、其他)、产品(外束放射治疗、内束放射治疗产品、放射治疗软件、全身放射治疗及其他)、应用(乳腺癌、肺癌、前列腺癌、结直肠癌、淋巴瘤、肝癌、甲状腺癌、脑癌、宫颈癌、脊柱癌、其他)、最终用户(医院、放射治疗中心、专科诊所、其他)、分销渠道(直接招标、零售销售、其他)、国家(南非、沙特阿拉伯、阿联酋、埃及、以色列、科威特和中东及非洲其他地区)、行业趋势和预测到 2029 年   

中东和非洲放射治疗市场

市场分析和洞察:中东和非洲放射治疗市场  

预计中东和非洲放射治疗市场将在 2022 年至 2029 年的预测期内实现市场增长。Data Bridge Market Research 分析称,在 2022 年至 2029 年的预测期内,该市场将以 4.5% 的复合年增长率增长,预计将从 2021 年的 1.5748 亿美元增至 2029 年的 2.2032 亿美元。癌症患病率的不断上升和放射治疗设备在癌症治疗中的应用日益增多是预计在预测期内推动市场需求的主要驱动因素。

放射治疗主要用于治疗癌症,使用 X 射线和类似形式的放射技术。在放射治疗中,高能放射线用于破坏致癌细胞并阻止其生长和分裂。放射治疗具有多种益处,可以准确直接地定位身体中任何位置的癌症。放射治疗程序在推出新的治疗计划软件和基于先进功能的治疗模式方面取得了进展,这需要高技能和认证的专业人员轻松操作这些产品和软件。

随着全球癌症患病率的上升,放射治疗需求也随之上升,与去年相比,放射治疗需求也有所增加。此外,随着人们越来越倾向于采用非手术方式治疗癌症,对放射治疗的需求也随之增加。例如:根据美国国家生物技术信息中心的数据,放射治疗癌症治疗有可能提高 350 万癌症患者的治愈率,还可以为另外 350 万癌症患者改善姑息治疗,每年新增癌症病例超过 1400 万。然而,放射治疗设备和面板的高成本可能会阻碍放射治疗的使用,预计在预测期内将减缓放射治疗市场的增长。 

Increasing cases of cancers globally and wide applications of radiotherapies are expected to provide an opportunity for the market. On the other hand, stringent government regulations for radioactive products are expected to act as a challenge for medical devices in the radiotherapy market.

The Middle East and Africa radiotherapy market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief. Our team will help you create a revenue impact solution to achieve your desired goal.

中东和非洲放射治疗市场

Middle East and Africa Radiotherapy Market Scope and Market Size

Middle East and Africa radiotherapy market is segmented into five notable segments which are based on type, product, application, end user, and distribution channel.

  • On the basis of type, the Middle East and Africa radiotherapy market is segmented into external-beam radiation therapy, internal radiation therapy, systemic radiotherapy/radiopharmaceuticals, and others. In 2022, the external-beam radiation therapy segment is expected to dominate in the market due to the high adoption of external-beam radiation therapy for the treatment of breast cancer, lung cancer, prostate cancer, colorectal cancer, lymphoma, liver cancer, thyroid cancer, brain cancer, cervical cancer, and spine cancer, among others.
  • On the basis of product, the Middle East and Africa radiotherapy market is segmented into external-beam radiation therapy, internal radiotherapy products, radiotherapy software, systemic radiotherapy, others. In 2022, the external beam radiotherapy segment is expected to dominate the market due to the increasing demand for external-beam radiation therapy devices such as LINAC, proton therapy, cyberknife, gamma knife for the treatment of breast cancer, lung cancer, prostate cancer, colorectal cancer, lymphoma, liver cancer, thyroid cancer, brain cancer, cervical cancer, and spine cancer, among others.
  • On the basis of application, the Middle East and Africa radiotherapy market is segmented into breast cancer, lung cancer, prostate cancer, colorectal cancer, lymphoma, liver cancer, thyroid cancer, brain cancer, cervical cancer, spine cancer, and others. In 2022, the breast cancer segment is expected to dominate the market due to the increasing prevalence of breast cancer across the world. Also, breast cancer is the most common cancer in women worldwide. In addition, according to the World Health Organization, in 2019, it is estimated that 168,690 new cases of invasive breast cancer were diagnosed in Africa.
  • On the basis of end user, the Middle East and Africa radiotherapy market is segmented into hospitals, radiation therapy centers, specialty clinics, and others. In 2022, the hospitals' segment is expected to dominate the market as the radiotherapy procedure is performed as an outpatient procedure in the hospital that normally takes less than 60 minutes and hospitals are one of the first contact points and the most trustable option for the patients in various countries for the treatment of cancer disease.
  • On the basis of distribution channel, the Middle East and Africa radiotherapy market is segmented into direct tender, retail sales, and others. In 2022, the direct tender segment is expected to dominate the market as most hospitals, radiation therapy centers, specialty clinics, ambulatory surgical centers, and academic and research organizations prefer direct tender for the benefits of bulk buying, discounts, and ready availability of products.

Middle East and Africa Radiotherapy Market Country Level Analysis

The Middle East and Africa radiotherapy market is analyzed, and market size information is provided by type, product, application, end user, and distribution channel.

The countries covered in the Radiotherapy market report are South Africa, Saudi Arabia, UAE, Egypt, Israel, Kuwait, and the rest of the Middle East and Africa.

South Africa is expected to dominate the Middle East and Africa radiotherapy market due to the presence of a large number of cancer cases.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of the Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.  

Strategic Initiatives By Manufacturers Is Creating New Opportunities For Players In The Radiotherapy Market 

Middle East and Africa radiotherapy market also provide you with detailed market analysis for every country growth in the aesthetic industry with radiotherapy sales, the impact of advancement in radiotherapy, and changes in regulatory scenarios with their support for the Radiotherapy market. The data is available for the historical period 2011 to 2020.  

Competitive Landscape and Radiotherapy Market Share Analysis

中东和非洲放射治疗市场竞争格局提供竞争对手的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对中东和非洲放射治疗市场的关注有关。

报告中涉及的一些主要参与者包括 Elekta AB (pub)、RaySearch Laboratories、Brainlab、Koninklijke Philips NV、通用电气公司、日立有限公司、SIT - SIT Sordina IORT Technologies SpA、住友重工有限公司、Xoft(iCAD, Inc. 的子公司)、ZEISS International 以及其他国内参与者。DBMR 分析师了解竞争优势并为每个竞争对手分别提供竞争分析。

全球各地的公司也发起了许多产品发布和协议,这也加速了中东和非洲放射治疗市场的发展。

例如,  

  • 2019 年 9 月,西门子医疗有限公司推出了两款专用 CT 系统,Somatom go.Sim 和 Somatom go.Open Pro,用于放射治疗规划。新系统使放射治疗规划更加准确。通过推出新产品,该公司增强了其产品组合,并为市场带来了足够的收入
  • 2019 年 4 月,荷兰皇家飞利浦公司推出了 IntelliSpace 放射肿瘤学,用于加快从患者转诊到开始治疗的时间。该解决方案用于管理复杂性、提高效率并实现放射治疗部门的卓越运营。通过推出新产品,该公司增强了其产品组合并为市场带来了足够的收入

市场参与者的合作、合资和其他策略正在增强公司在放射治疗市场的市场,这也为组织改善其放射治疗产品提供了好处。

 

 


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF MIDDLE EAST & AFRICA RADIOTHERAPY MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 MARKET APPLICATION COVERAGE GRID

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER'S 5 FORCES

5 REGULATIONS

5.1 BRACHYTHERAPY DEVICES REGULATIONS:

5.2 USE OF SOURCES FOR MANUAL BRACHYTHERAPY.

5.3 BRACHYTHERAPY SOURCES ACCOUNTABILITY.

5.4 EUROPE MEDICAL AGENCY REGULATION

5.5 UK

5.6 INDIA:

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 GROWING PREVALENCE OF CANCER DISEASE

6.1.2 NOVEL TECHNOLOGY IN RADIOTHERAPY FOR CANCER TREATMENT

6.1.3 INCREASING ADOPTION OF RADIOTHERAPY DEVICES AND PROCEDURES

6.1.4 RISING PREFERENCE FOR NON-SURGICAL PROCEDURES

6.2 RESTRAINTS

6.2.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS

6.2.2 COMPLEX NATURE OF RADIOTHERAPY

6.2.3 HIGH COST OF RADIOTHERAPY PROCEDURE

6.3 OPPORTUNITIES

6.3.1 INCREASING HEALTHCARE EXPENDITURE FOR CANCER TREATMENT

6.3.2 GROWING GOVERNMENT INITIATIVES TOWARDS CANCER TREATMENT

6.3.3 RISING PATIENTS AWARENESS TOWARDS CANCER TREATMENT

6.4 CHALLENGES

6.4.1 STRICT REGULATIONS AND STANDARDS FOR APPROVAL AND COMMERCIALIZATION OF RADIOTHERAPY PRODUCTS

6.4.2 RISK OF RADIATION EXPOSURE

7 IMPACT OF COVID-19 ON MIDDLE EAST & AFRICA RADIOTHERAPY MARKET

7.1 IMPACT ANALYSIS ON DEMAND

7.2 CONCLUSION

8 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET, BY TYPE

8.1 OVERVIEW

8.2 EXTERNAL-BEAM RADIATION THERAPY

8.2.1 IMAGE-GUIDED RADIATION THERAPY (IGRT)

8.2.2 PROTON BEAM THERAPY

8.2.3 STEREOTACTIC RADIATION THERAPY

8.2.4 INTENSITY MODULATED RADIATION THERAPY (IMRT)

8.2.5 THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY (3D-CRT)

8.2.6 VOLUMETRIC MODULATED ARC THERAPY (VMAT)

8.2.7 OTHERS

8.3 INTERNAL RADIATION THERAPY

8.3.1 BRACHYTHERAPY

8.3.1.1 HIGH DOSE BRACHYTHERAPY

8.3.1.2 LOW DOSE BRACHYTHERAPY

8.3.2 SELECTIVE INTERNAL RADIATION THERAPY (SIRT)

8.4 SYSTEMIC RADIOTHERAPY/ RADIOPHARMACEUTICALS

8.5 OTHERS

9 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET, BY PRODUCT

9.1 OVERVIEW

9.2 EXTERNAL BEAM RADIATION THERAPY

9.2.1 LINAC

9.2.2 PROTON THERAPY

9.2.2.1 SYNCHROTRON

9.2.2.2 CYCLOTRON

9.2.3 CYBER KNIFE

9.2.4 GAMMA KNIFE

9.2.5 OTHERS

9.3 INTERNAL RADIOTHERAPY PRODUCTS

9.3.1 SEEDS

9.3.2 ELECTRONIC BRACHYTHERAPY

9.3.3 APPLICATORS

9.3.4 AFTERLOADERS

9.3.5 OTHERS

9.4 RADIOTHERAPY SOFTWARE

9.4.1 IMAGE GUIDING SOFTWARE

9.4.2 TREATMENT PLANNING SOFTWARE

9.4.3 PATIENT POSITIONING SOFTWARE

9.4.4 DOSAGE PLANNING SOFTWARE

9.4.5 OTHERS

9.5 SYSTEMIC RADIOTHERAPY

9.5.1 ALPHA EMITTERS

9.5.2 BETA EMITTERS

9.6 OTHERS

10 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET, BY APPLICATION

10.1 OVERVIEW

10.2 BREAST CANCER

10.3 LUNG CANCER

10.4 PROSTATE CANCER

10.5 COLORECTAL CANCER

10.6 LYMPHOMA

10.7 LIVER CANCER

10.8 THYROID CANCER

10.9 BRAIN CANCER

10.1 CERVICAL CANCER

10.11 SPINE CANCER

10.12 OTHERS

11 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET, BY END USER

11.1 OVERVIEW

11.2 HOSPITALS

11.3 RADIATION THERAPY CENTERS

11.4 SPECIALTY CLINICS

11.5 OTHERS

12 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL

12.1 OVERVIEW

12.2 DIRECT TENDER

12.3 RETAIL SALES

12.4 OTHERS

13 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET, BY REGION

13.1 MIDDLE EAST AND AFRICA

13.1.1 SOUTH AFRICA

13.1.2 SAUDI ARABIA

13.1.3 UAE

13.1.4 EGYPT

13.1.5 ISRAEL

13.1.6 KUWAIT

13.1.7 REST OF MIDDLE EAST AND AFRICA

14 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA

15 SWOT ANALYSIS

16 COMPANY PROFILE

16.1 SIEMENS HEALTHCARE GMBH

16.1.1 COMPANY SNAPSHOT

16.1.2 REVENUE ANALYSIS

16.1.3 COMPANY SHARE ANALYSIS

16.1.4 PRODUCT PORTFOLIO

16.1.5 RECENT DEVELOPMENT

16.2 ELEKTA AB (PUB)

16.2.1 COMPANY SNAPSHOT

16.2.2 RECENT FINANCIALS

16.2.3 COMPANY SHARE ANALYSIS

16.2.4 PRODUCT PORTFOLIO

16.2.5 RECENT DEVELOPMENT

16.3 ACCURAY INCORPORATED

16.3.1 COMPANY SNAPSHOT

16.3.2 RECENT FINANCIALS

16.3.3 COMPANY SHARE ANALYSIS

16.3.4 PRODUCT PORTFOLIO

16.3.5 RECENT DEVELOPMENT

16.4 GENERAL ELECTRIC COMPANY

16.4.1 COMPANY SNAPSHOT

16.4.2 REVENUE ANALYSIS

16.4.3 COMPANY SHARE ANALYSIS

16.4.4 PRODUCT PORTFOLIO

16.4.5 RECENT DEVELOPMENT

16.5 IBA WORLDWIDE

16.5.1 COMPANY SNAPSHOT

16.5.2 RECENT FINANCIALS

16.5.3 COMPANY SHARE ANALYSIS

16.5.4 PRODUCT PORTFOLIO

16.5.5 RECENT DEVELOPMENT

16.6 ADVANCED ACCELERATOR APPLICATIONS (A SUBSIDIARY OF NOVARTIS AG)

16.6.1 COMPANY SNAPSHOT

16.6.2 REVENUE ANALYSIS

16.6.3 PRODUCT PORTFOLIO

16.6.4 RECENT DEVELOPMENT

16.7 ADVANCED ONCOTHERAPY

16.7.1 COMPANY SNAPSHOT

16.7.2 PRODUCT PORTFOLIO

16.8 ARIANE MEDICAL SYSTEMS LTD

16.8.1 COMPANY SNAPSHOT

16.8.2 PRODUCT PORTFOLIO

16.8.3 RECENT DEVELOPMENT

16.9 BRAINLAB

16.9.1 COMPANY SNAPSHOT

16.9.2 PRODUCT PORTFOLIO

16.9.3 RECENT DEVELOPMENT

16.1 CANON MEDICAL SYSTEMS CORPORATION

16.10.1 COMPANY SNAPSHOT

16.10.2 PRODUCT PORTFOLIO

16.10.3 RECENT DEVELOPMENT

16.11 CIVCO RADIOTHERAPY

16.11.1 COMPANY SNAPSHOT

16.11.2 PRODUCT PORTFOLIO

16.11.3 RECENT DEVELOPMENT

16.12 ECKERT & ZIEGLER BEBIG

16.12.1 COMPANY SNAPSHOT

16.12.2 RECENT FINANCIALS

16.12.3 PRODUCT PORTFOLIO

16.12.4 RECENT DEVELOPMENT

16.13 HITACHI, LTD.

16.13.1 COMPANY SNAPSHOT

16.13.2 REVENUE ANALYSIS

16.13.3 PRODUCT PORTFOLIO

16.13.4 RECENT DEVELOPMENT

16.14 INTRAOP MEDICAL, INC.

16.14.1 COMPANY SNAPSHOT

16.14.2 PRODUCT PORTFOLIO

16.14.3 RECENT DEVELOPMENT

16.15 ISORAY INC.

16.15.1 COMPANY SNAPSHOT

16.15.2 REVENUE ANALYSIS

16.15.3 PRODUCT PORTFOLIO

16.15.4 RECENT DEVELOPMENT

16.16 KONINKLIJKE PHILIPS N.V.

16.16.1 COMPANY SNAPSHOT

16.16.2 REVENUE ANALYSIS

16.16.3 PRODUCT PORTFOLIO

16.16.4 RECENT DEVELOPMENT

16.17 MEVION MEDICAL SYSTEMS

16.17.1 COMPANY SNAPSHOT

16.17.2 PRODUCT PORTFOLIO

16.17.3 RECENT DEVELOPMENT

16.18 MIRADA MEDICAL LIMITED

16.18.1 COMPANY SNAPSHOT

16.18.2 PRODUCT PORTFOLIO

16.18.3 RECENT DEVELOPMENT

16.19 NORDION (CANADA) INC. (A SUBSIDIARY OF SOTERA HEALTH)

16.19.1 COMPANY SNAPSHOT

16.19.2 REVENUE ANALYSIS

16.19.3 PRODUCT PORTFOLIO

16.19.4 RECENT DEVELOPMENT

16.2 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.

16.20.1 COMPANY SNAPSHOT

16.20.2 PRODUCT PORTFOLIO

16.20.3 RECENT DEVELOPMENT

16.21 P-CURE

16.21.1 COMPANY SNAPSHOT

16.21.2 PRODUCT PORTFOLIO

16.21.3 RECENT DEVELOPMENT

16.22 PROTOM INTERNATIONAL

16.22.1 COMPANY SNAPSHOT

16.22.2 PRODUCT PORTFOLIO

16.22.3 RECENT DEVELOPMENT

16.23 PROVISION HEALTHCARE

16.23.1 COMPANY SNAPSHOT

16.23.2 PRODUCT PORTFOLIO

16.23.3 RECENT DEVELOPMENT

16.24 RAYSEARCH LABORATORIES

16.24.1 COMPANY SNAPSHOT

16.24.2 REVENUE ANALYSIS

16.24.3 PRODUCT PORTFOLIO

16.24.4 RECENT DEVELOPMENT

16.25 SIT - S.I.T. SORDINA IORT TECHNOLOGIES S.P.A.

16.25.1 COMPANY SNAPSHOT

16.25.2 PRODUCT PORTFOLIO

16.26 SUMITOMO HEAVY INDUSTRIES, LTD.

16.26.1 COMPANY SNAPSHOT

16.26.2 REVENUE ANALYSIS

16.26.3 PRODUCT PORTFOLIO

16.26.4 RECENT DEVELOPMENT

16.27 VIEWRAY TECHNOLOGIES, INC. (“VIEWRAY”)

16.27.1 COMPANY SNAPSHOT

16.27.2 RECENT FINANCIALS

16.27.3 PRODUCT PORTFOLIO

16.27.4 RECENT DEVELOPMENT

16.28 XOFT, A SUBSIDIARY OF ICAD, INC.

16.28.1 COMPANY SNAPSHOT

16.28.2 REVENUE ANALYSIS

16.28.3 PRODUCT PORTFOLIO

16.28.4 RECENT DEVELOPMENT

16.29 ZEISS INTERNATIONAL

16.29.1 COMPANY SNAPSHOT

16.29.2 PRODUCT PORTFOLIO

16.29.3 RECENT DEVELOPMENT

17 QUESTIONNAIRE

18 RELATED REPORTS

表格列表

TABLE 1 MIDDLE EAST & AFRICA CANCER INCIDENCE (2018)

TABLE 2 MIDDLE EAST & AFRICA CANCER INCIDENCE (2018)

TABLE 3 MIDDLE EAST & AFRICA CANCER INCIDENCE (2018)

TABLE 4 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC

TABLE 5 PRODUCT CLASSIFICATION

TABLE 6 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 7 MIDDLE EAST & AFRICA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 8 MIDDLE EAST & AFRICA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 9 MIDDLE EAST & AFRICA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 10 MIDDLE EAST & AFRICA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 11 MIDDLE EAST & AFRICA BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 12 MIDDLE EAST & AFRICA SYSTEMIC RADIOTHERAPY/ RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 13 MIDDLE EAST & AFRICA OTHERS IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 14 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 15 MIDDLE EAST & AFRICA EXTERNAL BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 16 MIDDLE EAST & AFRICA EXTERNAL BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 17 MIDDLE EAST & AFRICA PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 18 MIDDLE EAST & AFRICA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 19 MIDDLE EAST & AFRICA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 20 MIDDLE EAST & AFRICA RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 21 MIDDLE EAST & AFRICA RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 22 MIDDLE EAST & AFRICA SYSTEMIC RADIOTHERAPY IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 23 MIDDLE EAST & AFRICA SYSTEMIC RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 24 MIDDLE EAST & AFRICA OTHERS IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 25 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 26 MIDDLE EAST & AFRICA BREAST CANCER IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 27 MIDDLE EAST & AFRICA LUNG CANCER IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 28 MIDDLE EAST & AFRICA PROSTATE CANCER IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 29 MIDDLE EAST & AFRICA COLORECTAL CANCER IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 30 MIDDLE EAST & AFRICA LYMPHOMA IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA LIVER CANCER IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA THYROID CANCER IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA BRAIN CANCER IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 34 MIDDLE EAST & AFRICA CERVICAL CANCER IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 35 MIDDLE EAST & AFRICA SPINE CANCER IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 36 MIDDLE EAST & AFRICA OTHERS IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 37 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 38 MIDDLE EAST & AFRICA HOSPITALS IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 39 MIDDLE EAST & AFRICA RADIATION THERAPY CENTERS IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA SPECIALTY CLINICS IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA OTHERS IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA DIRECT TENDER IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 44 MIDDLE EAST & AFRICA RETAIL SALES IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 45 MIDDLE EAST & AFRICA OTHERS IN RADIOTHERAPY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 46 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY COUNTRY, 2020-2029(USD MILLION)

TABLE 47 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 48 MIDDLE EAST AND AFRICA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 49 MIDDLE EAST AND AFRICA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 50 MIDDLE EAST AND AFRICA BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 51 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 52 MIDDLE EAST AND AFRICA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 53 MIDDLE EAST AND AFRICA PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 54 MIDDLE EAST AND AFRICA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 55 MIDDLE EAST AND AFRICA SYSTEMIC RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 56 MIDDLE EAST AND AFRICA RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 57 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 58 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 59 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 60 SOUTH AFRICA RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 61 SOUTH AFRICA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 62 SOUTH AFRICA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 63 SOUTH AFRICA BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 64 SOUTH AFRICA RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 65 SOUTH AFRICA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 66 SOUTH AFRICA PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 67 SOUTH AFRICA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 68 SOUTH AFRICA SYSTEMIC RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 69 SOUTH AFRICA RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 70 SOUTH AFRICA RADIOTHERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 71 SOUTH AFRICA RADIOTHERAPY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 72 SOUTH AFRICA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 73 SAUDI ARABIA RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 74 SAUDI ARABIA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 75 SAUDI ARABIA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 76 SAUDI ARABIA BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 77 SAUDI ARABIA RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 78 SAUDI ARABIA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 79 SAUDI ARABIA PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 80 SAUDI ARABIA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 81 SAUDI ARABIA SYSTEMIC RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 82 SAUDI ARABIA RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 83 SAUDI ARABIA RADIOTHERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 84 SAUDI ARABIA RADIOTHERAPY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 85 SAUDI ARABIA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 86 UAE RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 87 UAE EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 88 UAE INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 89 UAE BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 90 UAE RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 91 UAE EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 92 UAE PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 93 UAE INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 94 UAE SYSTEMIC RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 95 UAE RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 96 UAE RADIOTHERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 97 UAE RADIOTHERAPY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 98 UAE RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 99 EGYPT RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 100 EGYPT EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 101 EGYPT INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 102 EGYPT BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 103 EGYPT RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 104 EGYPT EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 105 EGYPT PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 106 EGYPT INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 107 EGYPT SYSTEMIC RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 108 EGYPT RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 109 EGYPT RADIOTHERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 110 EGYPT RADIOTHERAPY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 111 EGYPT RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 112 ISRAEL RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 113 ISRAEL EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 114 ISRAEL INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 115 ISRAEL BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 116 ISRAEL RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 117 ISRAEL EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 118 ISRAEL PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 119 ISRAEL INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 120 ISRAEL SYSTEMIC RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 121 ISRAEL RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 122 ISRAEL RADIOTHERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 123 ISRAEL RADIOTHERAPY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 124 ISRAEL RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 125 KUWAIT RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 126 KUWAIT EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 127 KUWAIT INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 128 KUWAIT BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 129 KUWAIT RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 130 KUWAIT EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 131 KUWAIT PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 132 KUWAIT INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 133 KUWAIT SYSTEMIC RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 134 KUWAIT RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 135 KUWAIT RADIOTHERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 136 KUWAIT RADIOTHERAPY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 137 KUWAIT RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 138 REST OF MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)

图片列表

FIGURE 1 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET : REGIONAL VS COUNTRY MARKET ANALYSIS

FIGURE 5 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET : COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET : MULTIVARIATE MODELLING

FIGURE 7 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: DBMR MARKET POSITION GRID

FIGURE 9 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: MARKET APPLICATION TYPE COVERAGE GRID

FIGURE 11 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: SEGMENTATION

FIGURE 12 GROWING PREVALENCE OF CANCER DISEASE AND NOVEL TECHNOLOGY IN RADIOTHERAPY FOR CANCER TREATMENT ARE EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA RADIOTHERAPY MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 13 EXTERNAL-BEAM RADIATION THERAPY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA RADIOTHERAPY MARKET IN 2022 & 2029

FIGURE 14 NORTH AMERICA IS EXPECTED TO DOMINATE THE MIDDLE EAST & AFRICA RADIOTHERAPY MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MIDDLE EAST & AFRICA RADIOTHERAPY MARKET

FIGURE 16 CANCER DEATH RATES BY AGE GROUP (2017)

FIGURE 17 NUMBER OF NEW CANCER CASES IN 2018, ALL AGES

FIGURE 18 NUMBER OF NEW CASES IN 2018, IN MALES, ALL AGES

FIGURE 19 NUMBER OF NEW CASES IN 2018, IN FEMALES, ALL AGES

FIGURE 20 ESTIMATED LIFETIME CARE SPENDING

FIGURE 21 OUT OF POCKET COSTS DURING CANCER

FIGURE 22 HEALTH SPENDING BY MAJOR SOURCES OF FUNDS

FIGURE 23 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: BY TYPE, 2021

FIGURE 24 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET, BY TYPE, 2020-2029 (USD MILLION)

FIGURE 25 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: BY TYPE, CAGR (2022-2029)

FIGURE 26 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: BY TYPE, LIFELINE CURVE

FIGURE 27 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: BY PRODUCT, 2021

FIGURE 28 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

FIGURE 29 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: BY PRODUCT, CAGR (2022-2029)

FIGURE 30 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 31 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: BY APPLICATION, 2021

FIGURE 32 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

FIGURE 33 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: BY APPLICATION, CAGR (2022-2029)

FIGURE 34 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 35 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: BY END USER, 2021

FIGURE 36 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET, BY END USER, 2020-2029 (USD MILLION)

FIGURE 37 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: BY END USER, CAGR (2022-2029)

FIGURE 38 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: BY END USER, LIFELINE CURVE

FIGURE 39 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: BY DISTRIBUTION CHANNEL, 2021

FIGURE 40 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

FIGURE 41 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)

FIGURE 42 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 43 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET: SNAPSHOT (2021)

FIGURE 44 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET: BY COUNTRY (2021)

FIGURE 45 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET: BY COUNTRY (2022 & 2029)

FIGURE 46 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET: BY COUNTRY (2021 & 2029)

FIGURE 47 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET: BY TYPE (2022-2029)

FIGURE 48 MIDDLE EAST & AFRICA RADIOTHERAPY MARKET: COMPANY SHARE 2021 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Middle East and Africa radiotherapy market is predicted to grow at a CAGR of 4.5% during the forecast period of 2022 to 2029.
The future market value of the Middle East and Africa radiotherapy market is expected to reach $220.32 million by 2029.
The major players in the Middle East and Africa radiotherapy market are Elekta AB (pub), RaySearch Laboratories, Brainlab, Koninklijke Philips N.V., General Electric Company, Hitachi LTD., SIT - S.I.T. Sordina IORT Technologies S.p.A., Sumitomo Heavy Industries, Ltd., Xoft, etc.
The countries covered in the Middle East and Africa radiotherapy market are South Africa, Saudi Arabia, UAE, Egypt, Israel, Kuwait, and the rest of the Middle East and Africa.